Sanofi
VARIANTS OF PORCINE TRYPSIN
Last updated:
Abstract:
The present invention relates to polypeptide variants of porcine trypsin, to nucleic acid molecules encoding these variants, and to host cells comprising such nucleic acid molecules. It also relates to the use of these variants in methods for producing insulin. The invention further relates to the use of these variants as medicaments, as food ingredients, or as feed ingredients and to the use of these variants within a process of manufacturing a food ingredient or a feed ingredient.
Status:
Application
Type:
Utility
Filling date:
22 Feb 2019
Issue date:
3 Dec 2020